MX9400070A - HETERO CYCLIC COMPOUNDS, A PROCEDURE TO PREPARE THEM, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. - Google Patents
HETERO CYCLIC COMPOUNDS, A PROCEDURE TO PREPARE THEM, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.Info
- Publication number
- MX9400070A MX9400070A MX9400070A MX9400070A MX9400070A MX 9400070 A MX9400070 A MX 9400070A MX 9400070 A MX9400070 A MX 9400070A MX 9400070 A MX9400070 A MX 9400070A MX 9400070 A MX9400070 A MX 9400070A
- Authority
- MX
- Mexico
- Prior art keywords
- prepare
- procedure
- contain
- pharmaceutical compositions
- cyclic compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Los compuestos de la fórmula (I): amidas heterocíclicas, son útiles como antagonistas de calcio, por ejemplo, en el tratamiento de condiciones relacionadas con la acumulación de calcio en las células del cerebro.The compounds of formula (I): heterocyclic amides, are useful as calcium antagonists, for example, in the treatment of conditions related to calcium accumulation in brain cells.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929226718A GB9226718D0 (en) | 1992-12-22 | 1992-12-22 | Compounds |
GB939321808A GB9321808D0 (en) | 1993-10-22 | 1993-10-22 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9400070A true MX9400070A (en) | 1994-07-29 |
Family
ID=26302202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9400070A MX9400070A (en) | 1992-12-22 | 1994-01-03 | HETERO CYCLIC COMPOUNDS, A PROCEDURE TO PREPARE THEM, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0675883A1 (en) |
JP (1) | JPH08504792A (en) |
KR (1) | KR950704284A (en) |
CN (1) | CN1092415A (en) |
AU (1) | AU5833494A (en) |
CA (1) | CA2152394A1 (en) |
MX (1) | MX9400070A (en) |
WO (1) | WO1994014786A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5677291A (en) * | 1993-12-10 | 1997-10-14 | Hoechst Marion Roussel, Inc. | Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols |
US5795876A (en) * | 1996-04-30 | 1998-08-18 | Hoechst Marion Rousssel, Inc. | Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols |
US5608095A (en) * | 1996-04-30 | 1997-03-04 | Hoechst Marion Roussel, Inc. | Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
JP3588734B2 (en) * | 1996-07-26 | 2004-11-17 | コニカミノルタホールディングス株式会社 | Electrophotographic photoreceptor |
US6114572A (en) * | 1996-11-20 | 2000-09-05 | Hoechst Marion Roussel, Inc. | Substituted phenols and thiophenols useful as antioxidant agents |
US6121463A (en) * | 1997-06-24 | 2000-09-19 | Hoechst Marion Roussel, Inc. | Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents |
US6133467A (en) * | 1997-06-25 | 2000-10-17 | Hoechst Marion Roussel, Inc. | 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol |
US6251919B1 (en) | 1998-02-27 | 2001-06-26 | Warner-Lambert | Heterocyclic substituted aniline calcium channel blockers |
US6166052A (en) | 1998-03-11 | 2000-12-26 | Warner-Lambert Company | Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers |
US6943168B2 (en) | 1998-06-30 | 2005-09-13 | Neuromed Technologies Inc. | Calcium channel inhibitors comprising benzhydril spaced from piperazine |
US6951862B2 (en) | 1998-06-30 | 2005-10-04 | Neuromed Technologies, Inc. | Calcium channel blockers comprising two benzhydril moieties |
US6387897B1 (en) * | 1998-06-30 | 2002-05-14 | Neuromed Technologies, Inc. | Preferentially substituted calcium channel blockers |
US7186726B2 (en) | 1998-06-30 | 2007-03-06 | Neuromed Pharmaceuticals Ltd. | Preferentially substituted calcium channel blockers |
ES2233493T3 (en) * | 1999-12-21 | 2005-06-16 | Mitsubishi Pharma Corporation | THERAPEUTIC AND / OR PROFILACTIC AGENTS FOR NERVOUS SYSTEM DISORDERS. |
CA2611639A1 (en) * | 2005-06-29 | 2007-01-04 | Merck & Co., Inc. | 4-fluoro-piperidine t-type calcium channel antagonists |
EP3813948A1 (en) | 2018-06-27 | 2021-05-05 | Cornell University | Substituted alkylphenols as hcn1 antagonists |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3233828A1 (en) * | 1982-09-11 | 1984-03-15 | Basf Ag, 6700 Ludwigshafen | ARYLOXYALKYLAMINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR CONTROLLING UNWANTED PLANT GROWTH |
DE3421810A1 (en) * | 1984-06-12 | 1985-12-12 | Basf Ag, 6700 Ludwigshafen | PHENYLALKYLAMINE - BIOREGULATORS |
DE3706585A1 (en) * | 1987-02-25 | 1988-09-08 | Schering Ag | ARYL- AND ARYLOXY-SUBSTITUTED TERT.-ALKYLENAMINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR PHARMACEUTICAL USE |
JPH06509069A (en) * | 1991-06-27 | 1994-10-13 | バージニア・コモンウェルス・ユニバーシティ | Sigma receptor ligands and their uses |
-
1993
- 1993-12-16 CA CA002152394A patent/CA2152394A1/en not_active Abandoned
- 1993-12-16 EP EP94904162A patent/EP0675883A1/en not_active Withdrawn
- 1993-12-16 JP JP6514808A patent/JPH08504792A/en active Pending
- 1993-12-16 WO PCT/EP1993/003629 patent/WO1994014786A1/en not_active Application Discontinuation
- 1993-12-16 AU AU58334/94A patent/AU5833494A/en not_active Abandoned
- 1993-12-16 KR KR1019950702552A patent/KR950704284A/en not_active Application Discontinuation
- 1993-12-21 CN CN93112958A patent/CN1092415A/en active Pending
-
1994
- 1994-01-03 MX MX9400070A patent/MX9400070A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1994014786A1 (en) | 1994-07-07 |
CA2152394A1 (en) | 1994-07-07 |
JPH08504792A (en) | 1996-05-21 |
AU5833494A (en) | 1994-07-19 |
KR950704284A (en) | 1995-11-17 |
CN1092415A (en) | 1994-09-21 |
EP0675883A1 (en) | 1995-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9400070A (en) | HETERO CYCLIC COMPOUNDS, A PROCEDURE TO PREPARE THEM, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ES2053451T3 (en) | A PROCEDURE FOR THE PREPARATION OF A COMPOUND THAT HAS USEFUL PHARMACOLOGICAL PROPERTIES. | |
PA8468401A1 (en) | COMPOUNDS FOR THE TREATMENT OF ISCHEMIA | |
ES2154674T3 (en) | DERIVATIVES OF 1,5-BENZODIACEPINS WITH ANTAGONIST OR AGONIST ACTIVITY OF CCK. | |
ES2054872T3 (en) | NEW DERIVATIVES OF BENCIMIDAZOLIN-2-OXO-1-CARBOXYLIC ACID USEFUL AS ANTAGONISTS OF 5-HT RECEPTORS. | |
ES2058185T3 (en) | DERIVATIVES OF CAMPTOTECINA AND PROCEDURE FOR ITS PREPARATION. | |
AR007961A1 (en) | CYCLOALKYL DERIVATIVES AS INHIBITORS OF BONE RESORPTION AND VITRONECTIN RECEPTOR ANTAGONISTS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATION. | |
ES2156934T3 (en) | COMPOUNDS THAT PRESENT A POWERFUL ACTIVITY OF CALCIUM ANTAGONISTS AND ANTIOXIDANTS AND THEIR USE AS CITOPROTECTING AGENTS. | |
ES2184797T3 (en) | USE OF SEROTONINE ANTAGONISTS (5HT3) FOR THE TREATMENT OF FIBROMIALGIA. | |
MX9300407A (en) | AZABICICLIC DERIVATIVES USED IN THE MANUFACTURE OF MEDICINES, CONTAINING COMPOSITIONS AND PROCEDURE FOR THE PREPARATION. | |
PA8550101A1 (en) | DERIVATIVES OF BENZAMIDA TIAZOL AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT THE PROLIFERATION OF CELLS, AND METHODS FOR USE | |
AR003220A1 (en) | ACILATED MELATONIN DERIVATIVES; PHARMACEUTICAL AND COSMETIC COMPOSITION AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT. | |
ECSP941104A (en) | DERIVATIVES OF 2,6 DIAMINOPURINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
AR003955A1 (en) | DERIVATIVES OF N- (INDOL-2-CARBONYL) -GLYCINAMIDES, PROCEDURE FOR THEIR OBTAINING AND COMPOSITIONS THAT CONTAIN THEM. | |
AR001020A1 (en) | DERIVATIVES OF PHENYLDICETONE, PROCEDURES TO PREPARE THEM, THE HERBICIDAL COMPOSITIONS THAT CONTAIN THEM AND THE PROCEDURE TO COMBAT THE GROWTH OF UNDESIRABLE PLANTS WITH SUCH DERIVATIVES. | |
ES2052603T3 (en) | DERIVATIVES OF BENCIMIDAZOLE, PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT CONTAIN THEM. | |
ES2089687T3 (en) | 4-PHENYL-PIRIDONES AND 4-PHENYL-2-ALCOXIPIRIDINAS SUBSTITUTED AS INHIBITORS OF HMG-COA-REDUCTASA. | |
AR010700A1 (en) | SUBSTITUTED PURINE DERIVATIVES, PROCEDURE FOR THEIR PREPARATION, EMPLOYMENT AND THEIR AGENT CONTAINING THEM | |
ES2096643T3 (en) | PIRIDILSULFONILUREAS AS HERBICIDES AND REGULATORS OF THE GROWTH OF PLANTS, PROCEDURES FOR ITS PREPARATION AND USE. | |
MX9202190A (en) | 2-SUBSTITUTED CARBOXYINDOLES THAT HAVE PHARMACEUTICAL ACTIVITY. | |
MX9205123A (en) | DERIVATIVES OF 5-HYDROXY-2-PIRIMIDINYL METHYLENE USEFUL AS ANTI-INFLAMMATORY AGENTS. | |
ES2093782T3 (en) | PIRIDAZINDIONAS AND ITS USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS. | |
ES2127263T3 (en) | NEW TRIEN-CHROMENIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
AR026209A1 (en) | BASIC MONOCICLIC COMPOUNDS WITH NK-2 ACTION ANTAGONIST, MANUFACTURING PROCESSES AND FORMULAS CONTAINING THEM | |
MX9300406A (en) | AZABICICLIC DERIVATIVES PROCEDURES FOR ITS PREPARATION AND COMPOSITIONS THAT CONTAIN THEM. |